v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | EUCTR2021-001665-20-HU |
Full text link
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-001665-20/HU |
First author
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
|
Contact
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
zsembery.akos@dent.semmelweis-univ.hu |
Registration date
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
2021-03-26 |
Recruitment status
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Recruiting |
Study design
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
RCT |
Allocation
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Randomized |
Design
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Parallel |
Masking
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Blind label |
Center
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
single-center |
Study aim
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Treatment |
Inclusion criteria
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
- antigen or PCR test verified COVID-19 pneumonia - age: 18-64 yrs - informed consent - CT-verified bilateral GGO > 50% (CORADS 6) - invasive ventillation within 48hrs - PaO2/FiO2 <200 (at PEEP > 5 H2O cm) - serum prokalcitonin < 0.5 ng/ml - serum ferritin > 500 ng/ml - 20 < BMI <45 - antigén teszttel vagy PCR-el igazolt COVID pneumonia - életkor: 18-64 év - a beteg vagy közeli hozzátartozója informált beleegyezését adta a vizsgálatba - CT-vel igazolt bilaterális GGO > 50% (CORADS 6) - bevonástól számított 48 órán belül intubált gépi lélegeztetett beteg - PaO2/FiO2 <200 (PEEP > 5 H2O cm mellett). - serum prokalcitonin szint < 0.5 ng/ml - serum ferritin > 500 ng/ml - 20 < BMI <45 |
Exclusion criteria
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
- hypernatremia - metabolic alkalosis - relevant concomitant disease (excluding well-controlled hypertension) - renal failure: se creatinin > 200 µM (on adequate volume tehrapy) - liver failure (se bilirubin > 34 µM) - hematologic disease - chronic immune and/or hemopoetic disease - bacterial infection (evaluated as serum prokalcitonin szint > 0.5 ng/ml, purulent sputum, unilateral pulmonary consolidation) - hypernatrémia - metabolikus alkalózis - releváns kísérőbetegség (kivétel jól beállított magasvérnyomás betegség) - veseelégtelenség: egyensúlyi se creatinin > 200 µM (adekvát volumenterápia ellenére) - májelégtelenség (se bilirubin > 34 µM) - ismert vérképzőszervi betegség - bármilyen immun/vérképzőszervrendszert érintő krónikus megbetegedés - bakteriális fertőzés valószínűsége (serum prokalcitonin szint > 0.5 ng/ml, purulens köpet, féloldali pulmonális konszolidáció) |
Number of arms
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
2 |
Funding
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Semmelweis University Department of Oralbiology |
Inclusion age min
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
18 |
Inclusion age max
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
64 |
Countries
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Hungary |
Type of patients
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Severe/critical disease at enrollment |
Severity scale
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
7: Severe/critical disease at enrollment |
Total sample size
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
200 |
primary outcome
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
- the change in PaO2/FiO2 (Horowitz index) - the number of Ventillator Free Days (VFD) in an interval of 28 days - az oxigenizációs index változása (Az artériás oxigéntenzió PaO2 és a belégzett oxigénfrakció (FiO2) hányadosának naptári nap során mért legrosszabb értéke) - Ventillator Free Days (VFD) (időintervallum: 28 nap) (endotrachealis intubáció / tracheostoma nélkül töltött idő) |
Notes
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Declared number of arm (3.0) differs from found arms (2.0) |
Phase
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Phase 2 |
Arms
Last imported at : April 22, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
[{"arm_notes": "nebulized 4.2% sodium bicarbonate", "treatment_id": 1213, "treatment_name": "Sodium bicarbonate", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |